Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Bordetella respiratory infections are common in people (B. pertussis) and in animals (B.
bronchiseptica). During the last two decades, much has been learned about the virulence …

Background: Pertussis vaccination has reduced the number of notified cases in
industrialized countries from peak years by more than 95%. The effect of recently …

Vaccine efficacies against typical pertussis after household exposure to Bordetella pertussis
were estimated to be 75.4% for an acellular five-component vaccine, 42.4% for an acellular …

In a pertussis vaccine efficacy trial in Germany we collected sera from vaccinees (DTaP or
DTP) after the third and fourth doses of vaccine or at comparable time periods in DT vaccine …

The recommendations in this report were developed to broaden the spectrum of
antimicrobial agents that are available for treatment and postexposure prophylaxis of …

Background Whooping cough is a highly contagious respiratory disease. Infants are at
highest risk of severe disease and death. Erythromycin for 14 days is currently …

Pertussis is a contagious, acute respiratory illness caused by the bacterial pathogen
Bordetella pertussis. Although it is widely believed that transmission of B. pertussis occurs …

Vaccine-preventable infectious diseases may be introduced into the healthcare setting and
pose a serious risk to vulnerable populations including immunocompromised patients …

Effective diphtheria, tetanus toxoids, whole-cell pertussis (DTwP) vaccines became
available in the 1930s, and they were put into routine use in the United States in the 1940s …